好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2009 Annual Meeting | Using AAN Guidelines and Best Current Evidence in Daily Practice

Saturday 04/10/10
02:15 PM - 06:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
PM Half-Day Course
Janis M. Miyasaki, MD, MEd, FAAN
Participants should be able to list the appropriate uses of botulinum toxin in neurologic illness; factors specific to women with epilepsy, including specific treatment guidelines; and appropriate techniques to assess the risk of falls.
No CME available
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Advanced
Practitioner, Fellow, Resident, Nurse
Event Timeline
02:15 PM - 02:45 PM Introduction to Evidence-Based Medicine
Gary S. Gronseth, MD, FAAN
02:45 PM - 03:05 PM Botulinum Toxin in Movement Disorders
Janis M. Miyasaki, MD, MEd, FAAN
03:05 PM - 03:25 PM Botulinum Toxin in Spasticity
Janis M. Miyasaki, MD, MEd, FAAN
03:25 PM - 03:50 PM Botulinum Toxin in Other Disorders
Janis M. Miyasaki, MD, MEd, FAAN
03:50 PM - 04:10 PM Break
04:10 PM - 04:30 PM Assessing the Risk of Falls
04:30 PM - 04:50 PM Epilepsy in Women
Cynthia L. Harden, MD
04:50 PM - 05:15 PM Neutralizing Antibodies
Douglas S. Goodin, MD
05:15 PM - 05:40 PM Natilzumab
Douglas S. Goodin, MD
05:40 PM - 06:00 PM Questions and Answers
Faculty Disclosures
Janis M. Miyasaki, MD, MEd, FAAN Dr. Miyasaki has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Miyasaki has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Miyasaki has received research support from PCORI. The institution of Dr. Miyasaki has received research support from Brain Canada. The institution of Dr. Miyasaki has received research support from Canadian Consortium on Neurodegeneration in Aging. The institution of Dr. Miyasaki has received research support from University Hospital Foundation. The institution of Dr. Miyasaki has received research support from Social Science and Health Research Council.
Cynthia L. Harden, MD Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Gary S. Gronseth, MD, FAAN Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Douglas S. Goodin, MD No disclosure on file